C.R. Bard (BCR): Q3 EPS of $1.62 beats by $0.02. Revenue of $719.2M (+6% Y/Y) misses by $6M. The...

|About: C. R. Bard, Inc. (BCR)|By:, SA News Editor
C.R. Bard (BCR): Q3 EPS of $1.62 beats by $0.02. Revenue of $719.2M (+6% Y/Y) misses by $6M. The medical technology provider also says it will buy privately-held Medivance for $250M. (earnings PR; acquisition PR)